Cargando…
MEK1/2-ERK Pathway Alterations as a Therapeutic Target in Sporadic Alzheimer’s Disease: A Study in Senescence-Accelerated OXYS Rats
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia worldwide, with no cure. There is growing interest in mitogen-activated protein kinases (MAPKs) as possible pathogenesis-related therapeutic targets in AD. Previously, using senescence-accelera...
Autores principales: | Muraleva, Natalia A., Kolosova, Nataliya G., Stefanova, Natalia A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8300733/ https://www.ncbi.nlm.nih.gov/pubmed/34208998 http://dx.doi.org/10.3390/antiox10071058 |
Ejemplares similares
-
Rapamycin suppresses brain aging in senescence-accelerated OXYS rats
por: Kolosova, Nataliya G., et al.
Publicado: (2013) -
SkQ1 Suppresses the p38 MAPK Signaling Pathway Involved in Alzheimer’s Disease-Like Pathology in OXYS Rats
por: Muraleva, Natalia A., et al.
Publicado: (2020) -
Association of cerebrovascular dysfunction with the development of Alzheimer’s disease-like pathology in OXYS rats
por: Stefanova, Natalia A., et al.
Publicado: (2018) -
Single-Nucleotide Polymorphisms (SNPs) Both Associated with Hypertension and Contributing to Accelerated-Senescence Traits in OXYS Rats
por: Devyatkin, Vasiliy A., et al.
Publicado: (2020) -
Amyloid accumulation is a late event in sporadic Alzheimer's disease-like pathology in nontransgenic rats
por: Stefanova, Natalia A., et al.
Publicado: (2014)